TROP2 CAR/IL-15 TGFBR2 KO NK cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TROP2 CAR/IL-15 TGFBR2 KO NK cells, covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum [Phase 1, Phase 2]